KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Acadia Pharmaceuticals (ACAD) over the last 10 years, with Q3 2025 value amounting to -$1.2 million.

  • Acadia Pharmaceuticals' Change in Inventory fell 19376.41% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year decrease of 7054.64%. This contributed to the annual value of $49.6 million for FY2024, which is 7200.08% up from last year.
  • As of Q3 2025, Acadia Pharmaceuticals' Change in Inventory stood at -$1.2 million, which was down 19376.41% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Change in Inventory registered a high of $27.1 million during Q2 2024, and its lowest value of -$1.2 million during Q3 2025.
  • Moreover, its 5-year median value for Change in Inventory was $1.3 million (2024), whereas its average is $4.9 million.
  • As far as peak fluctuations go, Acadia Pharmaceuticals' Change in Inventory tumbled by 26930.89% in 2022, and later skyrocketed by 496032.26% in 2023.
  • Over the past 5 years, Acadia Pharmaceuticals' Change in Inventory (Quarter) stood at -$217000.0 in 2021, then plummeted by 42.86% to -$310000.0 in 2022, then skyrocketed by 4960.32% to $15.1 million in 2023, then plummeted by 70.64% to $4.4 million in 2024, then crashed by 128.21% to -$1.2 million in 2025.
  • Its Change in Inventory stands at -$1.2 million for Q3 2025, versus $4.1 million for Q2 2025 and $10.5 million for Q1 2025.